Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221
Patient Information Leaflet last updated on the eMC: 03/11/2009
PIL Inspra 25 mg and 50 mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/11/2009 and displayed until Current
Reasons for adding or updating:
  • Change of manufacturer
Updated on 23/04/2008 and displayed until 03/11/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 01/10/2007 and displayed until 23/04/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to warnings or special precautions for use
  • Change due to harmonisation of patient information leaflet
Updated on 06/11/2006 and displayed until 01/10/2007
Reasons for adding or updating:
  • Change of manufacturer
Updated on 07/08/2006 and displayed until 06/11/2006
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 20/12/2004 and displayed until 07/08/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   eplerenone


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk